Thermo Fisher Scientific Inc. (TMO) is expected to report earnings on Wednesday, October 28, 2026, before the open. Estimated release time 06:03 ET. Consensus EPS estimate is $6.40.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-23 | FY2026 Q2 | $5.72 | $6.03 | +5.4% | $11.99B |
| 2026-05-01 | FY2026 Q1 | $5.25 | $5.44 | +3.6% | $11.01B |
| 2026-02-26 | FY2025 Q4 | $6.45 | $6.57 | +1.9% | $12.21B |
| 2025-10-31 | FY2025 Q3 | $5.50 | $5.79 | +5.3% | $11.12B |
| 2025-08-01 | FY2025 Q2 | $5.23 | $5.36 | +2.5% | $10.86B |
| 2025-05-02 | FY2025 Q1 | $5.10 | $5.15 | +1.0% | $10.36B |
| 2025-02-20 | FY2024 Q4 | $5.94 | $6.10 | +2.7% | $11.39B |
| 2024-11-01 | FY2024 Q3 | $5.25 | $5.28 | +0.6% | $10.60B |
TMO has beaten consensus EPS in 8 of its last 8 reported quarters.
See TMO on the live calendar →